News Archive

Are you a local engineering firm, technology-based company, or biohealth startup? Are you a STEM-based business in the Tri-State area? The Federal Laboratory Consortium is coming to Hagerstown on April 12, 2016 to share the latest technologies and research capabilities of the federal labs. NIST, NSA, NASA, NIH, & USDA will all be at Hagerstown Community College for the Small Business Forum from 9 a.m. to 3:30 p.m. Connect with representatives from each lab and discover how you can benefit from working with their lab.

SPIRIT OF INNOVATION: “We spend a lot of effort in recruitment to find the right culture fit,” says Gorkem Sevinc, CTO of emocha Mobile Health. What’s more, the solutions developed by Sevinc and his team help patients with medication and care plan adherence, a task that can literally save lives. “This drives our team to go above and beyond,” he says.

Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) announced today that additional data supporting the Company’s novel, investigational anti-cancer therapeutic, Supinoxin™ (RX-5902), for the treatment of triple negative breast cancer, were presented at the 14th Annual Targeted Anticancer Therapeutics Congress (TAT 2016), held in Washington, DC March 21- 23, 2016.

Our mission: improve newborn survival and health in the developing world

We are developing cutting edge healthcare technologies for where they’re gravely needed and will have an incredible impact—vulnerable populations in low-resource countries. Annually, over 46 million newborns in developing countries around the world need interventions for complications that happen at or around birth, 600,000 in Uganda alone. Every Neopenda device has the potential to save the life of a newborn for less than $1, once it is produced at scale.

For the last several years, Martine Rothblatt has been positioning United Therapeutics to manufacture transplantable human organs. This week, the founder and CEO of the Maryland biotech cornerstone told the state’s tech community to get ready for a new industry to sprout from the idea.

A Baltimore health startup is among the new class of companies entering Dreamit’s accelerator program.

Timonium-based Kermit was developed by a team that consulted for hospitals on the purchase of implantable medical devices for knees, hips and other body parts.

Join us on March 30th for an evening of networking around innovation and commercialization at the BioBuzz @ Relevant Health. Meet with the organizations fueling commercialization in Maryland – BHI & TEDCO – and mingle with the first cohort of companies in the regions newest BioHealth accelerator – Relevant Health.

DATE: Wednesday, April 13, 2016 (FINAL EVENT) TIME: 3:30-5:00PM

LOCATION: Montgomery County Department of Economic Development, 111 Rockville Pike, Suite 800, Rockville, MD 20850  

We would like to offer one of our best and brightest as our final speaker for the Tech Transfer Speakers Series.  Launching one successful company is challenging, but founding six or more is an art.  Plan to attend our final program on April 13 with one of our area’s prolific entrepreneurs.  Specific points of interest and discussion will include:  fundraising, launching the idea, identifying a technology that will sell, working with tech transfer officers to license the technology, and the future of innovation investment in the United States, Asia and Europe.  Bring your best questions.  This will be an exciting conversation! 

The Maryland Technology Development Corporation (TEDCO) announced today that 17 companies have received over $1.7 million in funding from the organization’s Technology Commercialization Fund (TCF) and Cyber Security Investment Fund (CIF)in the last six months. The funding will be used to advance the companies’ technology and product commercialization efforts.